Dr. Paula Muto reports

APPTLY'S UBERDOC PARTNERS WITH BRYLEOS, BRINGING WOMAN-OWNED CELLULAR-HEALTH INNOVATOR ONTO THE MARKETPLACE

Apptly Health Technologies Corp. has struck a strategic partnership with Bryleos (BioNADrx Holdings, Inc.), a woman-owned life sciences company focused on NAD+ science and oral cellular-health formulations.

Highlights

• Marketplace onboarding: Bryleos joins the UberDoc marketplace with a dedicated company presence, giving patients and physicians a direct line to its offerings;

• Broader platform reach: The partnership marks another step in executing Apptly's platform strategy, extending UberDoc's direct, transparent-access model beyond specialist care and adding a new offering to the ecosystem as the company builds toward multiple revenue streams across the platform;

• Patent-pending technology: Bryleos's patent-pending LathMized NAD+ platform is built around the metabolic changes associated with aging, recovery, and everyday cellular resilience;

• Published, peer-reviewed research: Bryleos grounds its work in randomized, placebo-controlled human research, with findings published in the peer-reviewed literature.

Through this partnership, UberDoc will feature Bryleos and its offerings within its platform and communications. As with any partner it features commercially, the company discloses that relationship in line with applicable advertising and endorsement guidelines. The company doesn't provide medical advice -- clinical and treatment decisions remain solely between patients and their physicians.

"UberDoc was built on a simple idea, that patients and physicians deserve direct, transparent access to the innovations shaping modern health," said Dr. Paula M. Muto, founder and interim chief executive officer of the company and a practicing vascular surgeon. "Our partnership with Bryleos reflects that same commitment. We are focused on building a trusted, transparent platform where patients and the physicians who serve them can explore credible options in one place, and we are glad to welcome Bryleos into that ecosystem."

"As a board member, I am proud that the company is partnering with Bryleos, a woman-owned life sciences company focused on cellular health that has invested in published, peer-reviewed human research," said John Dvor, a member of the company's board of directors. "Partnerships like this one expand what patients can discover on the UberDoc marketplace and reflect the standard we intend to hold for every company we bring onto the platform."

About Apptly Health Technologies Corp.

Apptly Health Technologies operates UberDoc, a direct-pay health-care marketplace that connects patients directly with board-certified specialists at transparent, upfront prices, with no referral requirements, no insurance barriers, and no surprise bills. With more than 5,000 specialist physicians and clinicians across 55-plus specialties in all 50 states, the platform provides patients with faster access to care while enabling physicians to expand patient access and grow their practices. The company was founded by Dr. Muto, MD.

We seek Safe Harbor.